
Results
87
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
87 companies
Chugai Pharmaceutical
Market Cap: JP¥11.5t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,011.00
7D
1.1%
1Y
11.8%
Zeria Pharmaceutical
Market Cap: JP¥94.9b
Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.
4559
JP¥2,153.00
7D
2.0%
1Y
3.9%
Tsumura
Market Cap: JP¥280.8b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,767.00
7D
0.4%
1Y
3.2%
Shionogi
Market Cap: JP¥2.5t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,919.00
7D
3.1%
1Y
13.1%
Fuji Pharma
Market Cap: JP¥48.2b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,847.00
7D
-0.2%
1Y
25.6%
Astellas Pharma
Market Cap: JP¥4.3t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,387.00
7D
1.3%
1Y
41.0%
Santen Pharmaceutical
Market Cap: JP¥603.7b
Engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,879.50
7D
-2.0%
1Y
19.3%
Daito PharmaceuticalLtd
Market Cap: JP¥39.2b
Engages in the manufacture and sale of pharmaceutical products in Japan and internationally.
4577
JP¥1,363.00
7D
3.4%
1Y
7.2%
Kissei Pharmaceutical
Market Cap: JP¥169.7b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan and internationally.
4547
JP¥4,095.00
7D
-1.7%
1Y
-5.4%
Kyowa Kirin
Market Cap: JP¥1.3t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,576.50
7D
-0.1%
1Y
-2.4%
ASKA Pharmaceutical HoldingsLtd
Market Cap: JP¥61.6b
Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.
4886
JP¥2,170.00
7D
2.8%
1Y
-14.6%
Sumitomo Pharma
Market Cap: JP¥633.2b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,411.50
7D
2.9%
1Y
-2.0%
Ono Pharmaceutical
Market Cap: JP¥1.2t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,448.00
7D
0.7%
1Y
47.4%
Daiichi Sankyo Company
Market Cap: JP¥5.2t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,833.50
7D
3.8%
1Y
-23.4%
Astena Holdings
Market Cap: JP¥21.8b
Manufactures and sells medicine-related products in Japan.
8095
JP¥538.00
7D
-0.2%
1Y
5.3%
Pharma Foods International
Market Cap: JP¥17.7b
Engages in the development and sale of functional food ingredients in Japan.
2929
JP¥608.00
7D
-0.7%
1Y
-41.1%
Sawai Group Holdings
Market Cap: JP¥188.5b
Together with subsidiaries, engages in the manufacture and sale of pharmaceuticals.
4887
JP¥1,632.00
7D
0%
1Y
-15.0%
Otsuka Holdings
Market Cap: JP¥6.4t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥12,195.00
7D
1.4%
1Y
51.2%
Shin Nippon Biomedical Laboratories
Market Cap: JP¥59.0b
A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.
2395
JP¥1,418.00
7D
-4.5%
1Y
-16.6%
Kaken Pharmaceutical
Market Cap: JP¥150.9b
Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.
4521
JP¥3,985.00
7D
-0.7%
1Y
2.7%
Nippon Shinyaku
Market Cap: JP¥247.2b
Manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally.
4516
JP¥3,667.00
7D
0.7%
1Y
13.7%
Healios K.K
Market Cap: JP¥36.5b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥270.00
7D
-0.7%
1Y
-52.9%
atect
Market Cap: JP¥2.9b
Engages in the sanitation inspection equipment, powder injection molding (PIM), and semiconductor material businesses in Japan, South Korea, Taiwan, and internationally.
4241
JP¥661.00
7D
-2.4%
1Y
51.3%
Takeda Pharmaceutical
Market Cap: JP¥9.2t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.
4502
JP¥5,764.00
7D
2.7%
1Y
25.6%
Towa Pharmaceutical
Market Cap: JP¥191.7b
Manufactures and sale ethical drugs in Japan.
4553
JP¥3,895.00
7D
2.6%
1Y
28.1%
Mochida Pharmaceutical
Market Cap: JP¥115.3b
Manufactures and sells pharmaceuticals and healthcare products in Japan.
4534
JP¥3,260.00
7D
0.3%
1Y
1.2%
KYORIN Pharmaceutical
Market Cap: JP¥66.5b
Through its subsidiaries, researches and develops, manufactures, and sells generic drugs in Japan and internationally.
4569
JP¥1,158.00
7D
3.6%
1Y
-26.0%
WDB coco
Market Cap: JP¥6.2b
Provides outsourcing and support services for pharmaceutical and medical device development in Japan.
7079
JP¥2,582.00
7D
-0.7%
1Y
-9.1%
CellSource
Market Cap: JP¥7.1b
Engages in the regenerative medicine-related businesses in Japan.
4880
JP¥356.00
7D
2.3%
1Y
-42.9%
Eisai
Market Cap: JP¥1.4t
Engages in the research, development, manufacture, and sale of pharmaceuticals in Japan.
4523
JP¥4,902.00
7D
0.9%
1Y
4.8%
Human Metabolome Technologies
Market Cap: JP¥3.4b
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.
6090
JP¥612.00
7D
2.0%
1Y
-18.9%
Noile-Immune Biotech
Market Cap: JP¥6.2b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥144.00
7D
1.4%
1Y
-23.8%
GNI Group
Market Cap: JP¥183.4b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥2,786.00
7D
-5.1%
1Y
4.3%
3-D Matrix
Market Cap: JP¥45.9b
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally.
7777
JP¥359.00
7D
-3.2%
1Y
58.8%
BrightPath Biotherapeutics
Market Cap: JP¥7.4b
Engages in the development of cancer immunotherapy drugs in Japan.
4594
JP¥53.00
7D
1.9%
1Y
-35.4%
Innovacell
Market Cap: JP¥28.6b
Develops, manufactures, and sells cell therapy and regenerative medicine products.
504A
JP¥633.00
7D
9.1%
1Y
n/a